Cargando…
1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report
BACKGROUND: Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir (TFV) disoproxil fumarate (FTC/TDF) is highly protective against HIV infection. We report the second case of acquisition of TDF-susceptible HIV despite high adherence to PrEP, confirmed by drug level testing. METHODS: PrEP adhe...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252599/ http://dx.doi.org/10.1093/ofid/ofy210.1131 |
_version_ | 1783373300128284672 |
---|---|
author | Cohen, Stephanie E Sachdev, Darpun Lee, Sulggi Scheer, Susan Bacon, Oliver Chen, Miao-Jung Norvell, Clarissa Ospina Okochi, Hideaki Anderson, Peter Coffey, Susa Scott, Hyman Havlir, Diane Gandhi, Monica |
author_facet | Cohen, Stephanie E Sachdev, Darpun Lee, Sulggi Scheer, Susan Bacon, Oliver Chen, Miao-Jung Norvell, Clarissa Ospina Okochi, Hideaki Anderson, Peter Coffey, Susa Scott, Hyman Havlir, Diane Gandhi, Monica |
author_sort | Cohen, Stephanie E |
collection | PubMed |
description | BACKGROUND: Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir (TFV) disoproxil fumarate (FTC/TDF) is highly protective against HIV infection. We report the second case of acquisition of TDF-susceptible HIV despite high adherence to PrEP, confirmed by drug level testing. METHODS: PrEP adherence was assessed by measuring FTC/TDF metabolites in dried blood spots (DBS) and FTC/TFV concentrations in segments of scalp hair. Genotypic and phenotypic resistance were evaluated. HIV partner services (PS) and HIV sequences reported to HIV surveillance with a genetic distance ≤1.5% (by HIV-Trace) identified likely transmission partners. RESULTS: A 21-year-old Latino man presented 13 months after PrEP initiation. He was HIV negative by rapid HIV antibody (Ab) and HIV RNA pooling (detection limit ~40 copies/mL) at PrEP initiation and at months 3, 6, and 10. At the 13-month visit, he was asymptomatic and his rapid HIV Ab was negative. Five days later, his HIV RNA was reported as positive (559 copies/mL). He was notified of the result, linked to care and immediately started antiretroviral treatment (ART), at which point his RNA was 1544 copies/mL and his HIV Ab test was positive. The HIV genotype had M184V, L74V and K103N mutations and phenotypic susceptibility to TDF. TFV/FTC levels by LC-MS/MS measured in 1 cm segments of hair collected at ART initiation indicated consistently high PrEP adherence in each of the preceding 6 months. TFV-diphosphate and FTC-triphosphate levels in DBS collected 2 days after ART initiation were 1012 fmol/punch and 0.266 pmol/punch, confirming high adherence over the preceding 6 weeks. Between PrEP initiation and HIV acquisition, he had 1 episode of urethral chlamydia and three episodes of urethral gonorrhea. The likely transmission partner, named during PS, had no history of viral suppression in HIV surveillance and harbored the same resistance mutations, with a genetic distance between the two patients of 0.66%. The partner was re-linked to care and had a current HIV RNA of 15,130 copies/mL. CONCLUSION: Acquisition of TDF-susceptible HIV infection can occur despite high PrEP adherence. Quarterly HIV and STD screening of patients on PrEP, combined with prompt linkage to care and PS for those diagnosed with HIV, facilitates early diagnosis and prevents further transmission of HIV. DISCLOSURES: S. E. Cohen, Gilead: Investigator in PrEP study for which Gilead donated drug, donated study drug and paid for drug testing during the PrEP demo project, of which I was a co-PI (the study has ended). S. Lee, Viiv Healthcare: Investigator, Research grant. Gilead Sciences: Investigator, Research grant. P. Anderson, Gilead: Consultant and Investigator, funds were paid to the institution for contract work and grant support and Research support. D. Havlir, Gilead: Investigator, Gilead Sciences provides antiretroviral therapy for a NIH funded study that she is conducting and Research support. |
format | Online Article Text |
id | pubmed-6252599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62525992018-11-28 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report Cohen, Stephanie E Sachdev, Darpun Lee, Sulggi Scheer, Susan Bacon, Oliver Chen, Miao-Jung Norvell, Clarissa Ospina Okochi, Hideaki Anderson, Peter Coffey, Susa Scott, Hyman Havlir, Diane Gandhi, Monica Open Forum Infect Dis Abstracts BACKGROUND: Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir (TFV) disoproxil fumarate (FTC/TDF) is highly protective against HIV infection. We report the second case of acquisition of TDF-susceptible HIV despite high adherence to PrEP, confirmed by drug level testing. METHODS: PrEP adherence was assessed by measuring FTC/TDF metabolites in dried blood spots (DBS) and FTC/TFV concentrations in segments of scalp hair. Genotypic and phenotypic resistance were evaluated. HIV partner services (PS) and HIV sequences reported to HIV surveillance with a genetic distance ≤1.5% (by HIV-Trace) identified likely transmission partners. RESULTS: A 21-year-old Latino man presented 13 months after PrEP initiation. He was HIV negative by rapid HIV antibody (Ab) and HIV RNA pooling (detection limit ~40 copies/mL) at PrEP initiation and at months 3, 6, and 10. At the 13-month visit, he was asymptomatic and his rapid HIV Ab was negative. Five days later, his HIV RNA was reported as positive (559 copies/mL). He was notified of the result, linked to care and immediately started antiretroviral treatment (ART), at which point his RNA was 1544 copies/mL and his HIV Ab test was positive. The HIV genotype had M184V, L74V and K103N mutations and phenotypic susceptibility to TDF. TFV/FTC levels by LC-MS/MS measured in 1 cm segments of hair collected at ART initiation indicated consistently high PrEP adherence in each of the preceding 6 months. TFV-diphosphate and FTC-triphosphate levels in DBS collected 2 days after ART initiation were 1012 fmol/punch and 0.266 pmol/punch, confirming high adherence over the preceding 6 weeks. Between PrEP initiation and HIV acquisition, he had 1 episode of urethral chlamydia and three episodes of urethral gonorrhea. The likely transmission partner, named during PS, had no history of viral suppression in HIV surveillance and harbored the same resistance mutations, with a genetic distance between the two patients of 0.66%. The partner was re-linked to care and had a current HIV RNA of 15,130 copies/mL. CONCLUSION: Acquisition of TDF-susceptible HIV infection can occur despite high PrEP adherence. Quarterly HIV and STD screening of patients on PrEP, combined with prompt linkage to care and PS for those diagnosed with HIV, facilitates early diagnosis and prevents further transmission of HIV. DISCLOSURES: S. E. Cohen, Gilead: Investigator in PrEP study for which Gilead donated drug, donated study drug and paid for drug testing during the PrEP demo project, of which I was a co-PI (the study has ended). S. Lee, Viiv Healthcare: Investigator, Research grant. Gilead Sciences: Investigator, Research grant. P. Anderson, Gilead: Consultant and Investigator, funds were paid to the institution for contract work and grant support and Research support. D. Havlir, Gilead: Investigator, Gilead Sciences provides antiretroviral therapy for a NIH funded study that she is conducting and Research support. Oxford University Press 2018-11-26 /pmc/articles/PMC6252599/ http://dx.doi.org/10.1093/ofid/ofy210.1131 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Cohen, Stephanie E Sachdev, Darpun Lee, Sulggi Scheer, Susan Bacon, Oliver Chen, Miao-Jung Norvell, Clarissa Ospina Okochi, Hideaki Anderson, Peter Coffey, Susa Scott, Hyman Havlir, Diane Gandhi, Monica 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report |
title | 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report |
title_full | 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report |
title_fullStr | 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report |
title_full_unstemmed | 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report |
title_short | 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report |
title_sort | 1298. acquisition of tdf-susceptible hiv despite high level adherence to daily tdf/ftc prep as measured by dried blood spot (dbs) and segmental hair analysis: a case report |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252599/ http://dx.doi.org/10.1093/ofid/ofy210.1131 |
work_keys_str_mv | AT cohenstephaniee 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT sachdevdarpun 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT leesulggi 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT scheersusan 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT baconoliver 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT chenmiaojung 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT norvellclarissaospina 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT okochihideaki 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT andersonpeter 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT coffeysusa 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT scotthyman 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT havlirdiane 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport AT gandhimonica 1298acquisitionoftdfsusceptiblehivdespitehighleveladherencetodailytdfftcprepasmeasuredbydriedbloodspotdbsandsegmentalhairanalysisacasereport |